Analysis of Smart Lung Tumour Detector and Stage Classifier Using Deep Learning Techniques with Internet of Things.

The use of artificial intelligence (AI) and the Internet of Things (IoT), which is a developing technology in medical applications that assists physicians in making more informed decisions regarding patients' courses of treatment, has become increasingly widespread in recent years in the field of healthcare. On the other hand, the number of PET scans that are being performed is rising, and radiologists are getting significantly overworked as a result. As a direct result of this, a novel approach that goes by the name "computer-aided diagnostics" is now being investigated as a potential method for reducing the tremendous workloads. A Smart Lung Tumor Detector and Stage Classifier (SLD-SC) is presented in this study as a hybrid technique for PET scans. This detector can identify the stage of a lung tumour. Following the development of the modified LSTM for the detection of lung tumours, the proposed SLD-SC went on to develop a Multilayer Convolutional Neural Network (M-CNN) for the classification of the various stages of lung cancer. This network was then modelled and validated utilising standard benchmark images. The suggested SLD-SC is now being evaluated on lung cancer pictures taken from patients with the disease. We observed that our recommended method gave good results when compared to other tactics that are currently being used in the literature. These findings were outstanding in terms of the performance metrics accuracy, recall, and precision that were assessed. As can be shown by the much better outcomes that were achieved with each of the test images that were used, our proposed method excels its rivals in a variety of respects. In addition to this, it achieves an average accuracy of 97 percent in the categorization of lung tumours, which is much higher than the accuracy achieved by the other approaches.

Integrated QSAR and Adverse Outcome Pathway Analysis of Chemicals Released on 3D Printing Using Acrylonitrile Butadiene Styrene.

Additive manufacturing commonly known as 3D printing has numerous applications in several domains including material and biomedical technologies and has emerged as a tool of capabilities by providing fast, highly customized, and cost-effective solutions. However, the impact of the printing materials and chemicals present in the printing fumes has raised concerns about their adverse potential affecting humans and the environment. Thus, it is necessary to understand the properties of the chemicals emitted during additive manufacturing for developing safe and biocompatible fibers having controlled emission of fumes including its sustainable usage. Therefore, in this study, we have developed a computational predictive risk-assessment framework on the comprehensive list of chemicals released during 3D printing using the acrylonitrile butadiene styrene (ABS) filament. Our results showed that the chemicals present in the fumes of the ABS-based fiber used in additive manufacturing have the potential to lead to various toxicity end points such as inhalation toxicity, oral toxicity, carcinogenicity, hepatotoxicity, and teratogenicity. Moreover, because of their absorption, distribution in the body, metabolism, and excretion properties, most of the chemicals exhibited a high absorption level in the intestine and the potential to cross the blood-brain barrier. Furthermore, pathway analysis revealed that signaling like alpha-adrenergic receptor signaling, heterotrimeric G-protein signaling, and Alzheimer's disease-amyloid secretase pathway are significantly overrepresented given the identified target proteins of these chemicals. These findings signify the adversities associated with 3D printing fumes and the necessity for the development of biodegradable and considerably safer fibers for 3D printing technology.